AI assistant
Sending…
CONMED Corp — Director's Dealing 2013
Jan 4, 2013
31971_dirs_2013-01-04_51894a45-e801-4f9d-b846-dc2237b5f427.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2013-01-02
Reporting Person: CORASANTI EUGENE R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-01-02 | Common Stock | M | 52833 | $25.03 | Acquired | 122547 | Direct |
| 2013-01-02 | Common Stock | S | 52833 | $28.10 | Disposed | 69714 | Direct |
| 2013-01-03 | Common Stock | M | 390 | $25.03 | Acquired | 70104 | Direct |
| 2013-01-03 | Common Stock | S | 390 | $28.10 | Disposed | 69714 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-01-02 | Options To Purchase Common Stock | $25.03 | M | 52833 | Disposed | 2014-05-18 | Common Stock (52833) | Direct |
| 2013-01-03 | Options To Purchase Common Stock | $25.03 | M | 390 | Disposed | 2014-05-18 | Common Stock (390) | Direct |
Footnotes
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 14, 2012.
F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 14, 2012.
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7